Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan
低剂量螺内酯联合ACEI/ARB类药物可能降低CKD 3b-5期患者的心血管事件发生率：一项台湾全国性人群队列研究
期刊:International Journal of Medical Sciences
影响因子:3.2
doi:10.7150/ijms.103390
Chien, Li-Nien; Hsiao, Po-Jen; Chiu, Chih-Chien; Chen, Wan-Ting; Cheng, Chih-Jen; Tsou, Leon Li-Ming; Kao, Yung-Hsi; Chou, Chu-Lin; Fang, Te-Chao
